Nadim Ahmed - Oct 18, 2021 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Oct 18, 2021
Transactions value $
$0
Form type
4
Date filed
10/20/2021, 04:35 PM
Next filing
Mar 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Award $0 +2.71M $0.00 2.71M Oct 18, 2021 Common Stock 2.71M $21.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 2,710,000 shares of the Issuer's Common Stock, which shall vest on a pro-rated basis commencing on October 18, 2021, with 1/48 of the shares vesting on a monthly basis over four years, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.